APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bilobalide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bilobalide Market Outlook and Growth Opportunities 2026

24 December 2025194 pages

Choose your research edition.

Industry ResearchBilobalide Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Bilobalide Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Bilobalide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bilobalide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Bilobalide Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Bilobalide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bilobalide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bilobalide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bilobalide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bilobalide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bilobalide market include AOBIOUS, Enzo Life Sciences, TCI America, ChemFaces, BioVision, Adipogen and BOC Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bilobalide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bilobalide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bilobalide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bilobalide market size, projected growth trends, production technologies, key applications, and end-use industries.

Bilobalide Segment by Company

AOBIOUS

Enzo Life Sciences

TCI America

ChemFaces

BioVision

Adipogen

BOC Sciences

Bilobalide Segment by Type

0.98

0.99

Others

Bilobalide Segment by Application

Medicine

Food and Beverage

Others

Bilobalide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bilobalide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bilobalide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bilobalide significant trends, drivers, influence factors in global and regions.

6. To analyze Bilobalide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bilobalide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bilobalide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bilobalide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bilobalide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bilobalide industry.

Chapter 3: Detailed analysis of Bilobalide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bilobalide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bilobalide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bilobalide Industry Trends Table 2. Bilobalide Industry Drivers Table 3. Bilobalide Industry Opportunities and Challenges Table 4. Bilobalide Industry Restraints Table 5. Global Bilobalide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bilobalide Revenue Share by Company (2021-2026) Table 7. Global Bilobalide Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Bilobalide Sales Volume Share by Company (2021-2026) Table 9. Global Bilobalide Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Bilobalide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bilobalide Key Company Manufacturing Base & Headquarters Table 12. Global Bilobalide Company, Product Type & Application Table 13. Global Bilobalide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bilobalide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.98 Table 18. Significant Companies of 0.99 Table 19. Significant Companies of Others Table 20. Global Bilobalide Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Bilobalide Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Bilobalide Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Bilobalide Sales Volume Share by Type (2021-2026) Table 24. Global Bilobalide Sales Volume Share by Type (2027-2032) Table 25. Global Bilobalide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bilobalide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Bilobalide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Bilobalide Sales Value Share by Type (2021-2026) Table 29. Global Bilobalide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Medicine Table 31. Significant Companies of Food and Beverage Table 32. Significant Companies of Others Table 33. Global Bilobalide Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Bilobalide Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Bilobalide Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Bilobalide Sales Volume Share by Application (2021-2026) Table 37. Global Bilobalide Sales Volume Share by Application (2027-2032) Table 38. Global Bilobalide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bilobalide Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Bilobalide Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Bilobalide Sales Value Share by Application (2021-2026) Table 42. Global Bilobalide Sales Value Share by Application (2027-2032) Table 43. Global Bilobalide Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Bilobalide Sales by Region (2021-2026) & (Tons) Table 45. Global Bilobalide Sales Market Share by Region (2021-2026) Table 46. Global Bilobalide Sales by Region (2027-2032) & (Tons) Table 47. Global Bilobalide Sales Market Share by Region (2027-2032) Table 48. Global Bilobalide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Bilobalide Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Bilobalide Sales Value Share by Region (2021-2026) Table 51. Global Bilobalide Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Bilobalide Sales Value Share by Region (2027-2032) Table 53. Global Bilobalide Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Bilobalide Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Bilobalide Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Bilobalide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Bilobalide Sales by Country (2021-2026) & (Tons) Table 58. Global Bilobalide Sales Market Share by Country (2021-2026) Table 59. Global Bilobalide Sales by Country (2027-2032) & (Tons) Table 60. Global Bilobalide Sales Market Share by Country (2027-2032) Table 61. Global Bilobalide Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Bilobalide Sales Value Market Share by Country (2021-2026) Table 63. Global Bilobalide Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Bilobalide Sales Value Market Share by Country (2027-2032) Table 65. AOBIOUS Company Information Table 66. AOBIOUS Business Overview Table 67. AOBIOUS Bilobalide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. AOBIOUS Bilobalide Product Portfolio Table 69. AOBIOUS Recent Development Table 70. Enzo Life Sciences Company Information Table 71. Enzo Life Sciences Business Overview Table 72. Enzo Life Sciences Bilobalide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Enzo Life Sciences Bilobalide Product Portfolio Table 74. Enzo Life Sciences Recent Development Table 75. TCI America Company Information Table 76. TCI America Business Overview Table 77. TCI America Bilobalide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. TCI America Bilobalide Product Portfolio Table 79. TCI America Recent Development Table 80. ChemFaces Company Information Table 81. ChemFaces Business Overview Table 82. ChemFaces Bilobalide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. ChemFaces Bilobalide Product Portfolio Table 84. ChemFaces Recent Development Table 85. BioVision Company Information Table 86. BioVision Business Overview Table 87. BioVision Bilobalide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. BioVision Bilobalide Product Portfolio Table 89. BioVision Recent Development Table 90. Adipogen Company Information Table 91. Adipogen Business Overview Table 92. Adipogen Bilobalide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Adipogen Bilobalide Product Portfolio Table 94. Adipogen Recent Development Table 95. BOC Sciences Company Information Table 96. BOC Sciences Business Overview Table 97. BOC Sciences Bilobalide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. BOC Sciences Bilobalide Product Portfolio Table 99. BOC Sciences Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Bilobalide Distributors List Table 103. Bilobalide Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Bilobalide Product Image Figure 2. Global Bilobalide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bilobalide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bilobalide Sales (2021-2032) & (Tons) Figure 5. Global Bilobalide Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Bilobalide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.98 Image Figure 10. 0.99 Image Figure 11. Others Image Figure 12. Global Bilobalide Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Bilobalide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Bilobalide Sales Volume Share by Type (2021-2032) Figure 15. Global Bilobalide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bilobalide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bilobalide Sales Value Share by Type (2021-2032) Figure 18. Medicine Image Figure 19. Food and Beverage Image Figure 20. Others Image Figure 21. Global Bilobalide Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Bilobalide Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Bilobalide Sales Volume Share by Application (2021-2032) Figure 24. Global Bilobalide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Bilobalide Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Bilobalide Sales Value Share by Application (2021-2032) Figure 27. Global Bilobalide Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Bilobalide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Bilobalide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Bilobalide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Bilobalide Sales Value (2021-2032) & (US$ Million) Figure 32. North America Bilobalide Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Bilobalide Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Bilobalide Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Bilobalide Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Bilobalide Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Bilobalide Sales Value (2021-2032) & (US$ Million) Figure 38. South America Bilobalide Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Bilobalide Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Bilobalide Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Bilobalide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Bilobalide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Bilobalide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Bilobalide Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Bilobalide Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 0.98
  • 0.99
  • Others
Applications
  • Medicine
  • Food and Beverage
  • Others
Companies covered
  • AOBIOUS
  • Enzo Life Sciences
  • TCI America
  • ChemFaces
  • BioVision
  • Adipogen
  • BOC Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bilobalide Sales Value (2021-2032)
  4. 1.2.2 Global Bilobalide Sales Volume (2021-2032)
  5. 1.2.3 Global Bilobalide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bilobalide Market Dynamics
  1. 2.1 Bilobalide Industry Trends
  2. 2.2 Bilobalide Industry Drivers
  3. 2.3 Bilobalide Industry Opportunities and Challenges
  4. 2.4 Bilobalide Industry Restraints
3 Bilobalide Market by Company
  1. 3.1 Global Bilobalide Company Revenue Ranking in 2025
  2. 3.2 Global Bilobalide Revenue by Company (2021-2026)
  3. 3.3 Global Bilobalide Sales Volume by Company (2021-2026)
  4. 3.4 Global Bilobalide Average Price by Company (2021-2026)
  5. 3.5 Global Bilobalide Company Ranking (2024-2026)
  6. 3.6 Global Bilobalide Company Manufacturing Base and Headquarters
  7. 3.7 Global Bilobalide Company Product Type and Application
  8. 3.8 Global Bilobalide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bilobalide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bilobalide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bilobalide Market by Type
  1. 4.1 Bilobalide Type Introduction
  2. 4.1.1 0.98
  3. 4.1.2 0.99
  4. 4.1.3 Others
  5. 4.2 Global Bilobalide Sales Volume by Type
  6. 4.2.1 Global Bilobalide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bilobalide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Bilobalide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Bilobalide Sales Value by Type
  10. 4.3.1 Global Bilobalide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bilobalide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Bilobalide Sales Value Share by Type (2021-2032)
5 Bilobalide Market by Application
  1. 5.1 Bilobalide Application Introduction
  2. 5.1.1 Medicine
  3. 5.1.2 Food and Beverage
  4. 5.1.3 Others
  5. 5.2 Global Bilobalide Sales Volume by Application
  6. 5.2.1 Global Bilobalide Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bilobalide Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Bilobalide Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Bilobalide Sales Value by Application
  10. 5.3.1 Global Bilobalide Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bilobalide Sales Value by Application (2021-2032)
  12. 5.3.3 Global Bilobalide Sales Value Share by Application (2021-2032)
6 Bilobalide Regional Sales and Value Analysis
  1. 6.1 Global Bilobalide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bilobalide Sales by Region (2021-2032)
  3. 6.2.1 Global Bilobalide Sales by Region: 2021-2026
  4. 6.2.2 Global Bilobalide Sales by Region (2027-2032)
  5. 6.3 Global Bilobalide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bilobalide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bilobalide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bilobalide Sales Value by Region (2027-2032)
  9. 6.5 Global Bilobalide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bilobalide Sales Value (2021-2032)
  12. 6.6.2 North America Bilobalide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bilobalide Sales Value (2021-2032)
  15. 6.7.2 Europe Bilobalide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bilobalide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bilobalide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bilobalide Sales Value (2021-2032)
  21. 6.9.2 South America Bilobalide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bilobalide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bilobalide Sales Value Share by Country, 2025 VS 2032
7 Bilobalide Country-level Sales and Value Analysis
  1. 7.1 Global Bilobalide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bilobalide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bilobalide Sales by Country (2021-2032)
  4. 7.3.1 Global Bilobalide Sales by Country (2021-2026)
  5. 7.3.2 Global Bilobalide Sales by Country (2027-2032)
  6. 7.4 Global Bilobalide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bilobalide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bilobalide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bilobalide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bilobalide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bilobalide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bilobalide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bilobalide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bilobalide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bilobalide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bilobalide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bilobalide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bilobalide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bilobalide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bilobalide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bilobalide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bilobalide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bilobalide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bilobalide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bilobalide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bilobalide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bilobalide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bilobalide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bilobalide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bilobalide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bilobalide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bilobalide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bilobalide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bilobalide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bilobalide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bilobalide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bilobalide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bilobalide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bilobalide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bilobalide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bilobalide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bilobalide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bilobalide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bilobalide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bilobalide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bilobalide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bilobalide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bilobalide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bilobalide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bilobalide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bilobalide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bilobalide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bilobalide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bilobalide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bilobalide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bilobalide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bilobalide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bilobalide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bilobalide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bilobalide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bilobalide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bilobalide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bilobalide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bilobalide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bilobalide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bilobalide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bilobalide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bilobalide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bilobalide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bilobalide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bilobalide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bilobalide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bilobalide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bilobalide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bilobalide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bilobalide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bilobalide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bilobalide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bilobalide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bilobalide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bilobalide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bilobalide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bilobalide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bilobalide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bilobalide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bilobalide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bilobalide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bilobalide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bilobalide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bilobalide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bilobalide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bilobalide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AOBIOUS
  2. 8.1.1 AOBIOUS Company Information
  3. 8.1.2 AOBIOUS Business Overview
  4. 8.1.3 AOBIOUS Bilobalide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AOBIOUS Bilobalide Product Portfolio
  6. 8.1.5 AOBIOUS Recent Developments
  7. 8.2 Enzo Life Sciences
  8. 8.2.1 Enzo Life Sciences Company Information
  9. 8.2.2 Enzo Life Sciences Business Overview
  10. 8.2.3 Enzo Life Sciences Bilobalide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Enzo Life Sciences Bilobalide Product Portfolio
  12. 8.2.5 Enzo Life Sciences Recent Developments
  13. 8.3 TCI America
  14. 8.3.1 TCI America Company Information
  15. 8.3.2 TCI America Business Overview
  16. 8.3.3 TCI America Bilobalide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 TCI America Bilobalide Product Portfolio
  18. 8.3.5 TCI America Recent Developments
  19. 8.4 ChemFaces
  20. 8.4.1 ChemFaces Company Information
  21. 8.4.2 ChemFaces Business Overview
  22. 8.4.3 ChemFaces Bilobalide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ChemFaces Bilobalide Product Portfolio
  24. 8.4.5 ChemFaces Recent Developments
  25. 8.5 BioVision
  26. 8.5.1 BioVision Company Information
  27. 8.5.2 BioVision Business Overview
  28. 8.5.3 BioVision Bilobalide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BioVision Bilobalide Product Portfolio
  30. 8.5.5 BioVision Recent Developments
  31. 8.6 Adipogen
  32. 8.6.1 Adipogen Company Information
  33. 8.6.2 Adipogen Business Overview
  34. 8.6.3 Adipogen Bilobalide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Adipogen Bilobalide Product Portfolio
  36. 8.6.5 Adipogen Recent Developments
  37. 8.7 BOC Sciences
  38. 8.7.1 BOC Sciences Company Information
  39. 8.7.2 BOC Sciences Business Overview
  40. 8.7.3 BOC Sciences Bilobalide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 BOC Sciences Bilobalide Product Portfolio
  42. 8.7.5 BOC Sciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bilobalide Value Chain Analysis
  2. 9.1.1 Bilobalide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bilobalide Sales Mode & Process
  6. 9.2 Bilobalide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bilobalide Distributors
  9. 9.2.3 Bilobalide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst